Melanoma Journal Articles for January 2020

BJD

Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease

  1. WeberV. GlutschE. Geissinger L. Haug J.F. Lock F. Schneider H. Kneitz M. Goebeler B. Schilling A. Gesierich

 

First published: 26 November 2019 https://doi.org/10.1111/bjd.18739


Nature Communications

Siah2 control of T-regulatory cells limits anti-tumor immunity

Marzia ScortegagnaKathryn HockemeyerIgor DolgalevJoanna Po?niakFlorian RambowYan LiYongmei FengRoberto TinocoDennis C. OteroTongwu ZhangKevin BrownMarcus BosenbergLinda M. BradleyJean-Christophe MarineIoannis Aifantis & Ze’ev A. Ronai 

Nature Communications volume 11, Article number: 99 (2020) 


Cells

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity

by Mariusz L. Hartman,Malgorzata Sztiller-Sikorska,Anna Gajos-Michniewicz andMalgorzata Czyz *

Cells 20209(1), 142; https://doi.org/10.3390/cells9010142

Received: 29 November 2019 / Revised: 29 December 2019 / Accepted: 3 January 2020 / Published: 7 January 2020


JAMA

Ophthalmic Images

January 9, 2020

Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation

Thibaud Mathis, MD1Jean-Pierre Caujolle, MD2Juliette Thariat, MD, PhD3

JAMA Ophthalmol. 2020;138(1):e190388. doi:10.1001/jamaophthalmol.2019.0388


Clinical Science

The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma

Jinyu Yu ; Jiayi Yu ; Xiaowen Wu ; Qian Guo ; Ting Yin ; Zhiyuan Cheng ; Jie Dai ; Yan Kong ; Jun Guo

Clin Sci (Lond) (2020) CS20190890.

https://doi.org/10.1042/CS20190890


JAMA

Original Investigation

November 13, 2019

Age-Specific Incidence of Melanoma in the United States

Kelly G. Paulson, MD, PhD1,2,3Deepti Gupta, MD4,5,6Teresa S. Kim, MD3,7; et alJoshua R. Veatch, MD, PhD1,2,3David R. Byrd, MD3,7Shailender Bhatia, MD1,2,3Katherine Wojcik, PhD1Aude G. Chapuis, MD1,2,3John A. Thompson, MD1,2,3Margaret M. Madeleine, PhD, MPH8,9Jennifer M. Gardner, MD3,5

JAMA Dermatol. 2020;156(1):57-64. doi:10.1001/jamadermatol.2019.3353


Siah2 control of T-regulatory cells limits anti-tumor immunity

Marzia ScortegagnaKathryn HockemeyerIgor DolgalevJoanna Po?niakFlorian RambowYan LiYongmei FengRoberto TinocoDennis C. OteroTongwu ZhangKevin BrownMarcus BosenbergLinda M. BradleyJean-Christophe MarineIoannis Aifantis & Ze’ev A. Ronai 

Nature Communications volume 11, Article number: 99 (2020) 


Cells

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity

by Mariusz L. Hartman,Malgorzata Sztiller-Sikorska,Anna Gajos-Michniewicz andMalgorzata Czyz *

Cells 20209(1), 142; https://doi.org/10.3390/cells9010142

Received: 29 November 2019 / Revised: 29 December 2019 / Accepted: 3 January 2020 / Published: 7 January 2020


JAMA

Ophthalmic Images

January 9, 2020

Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation

Thibaud Mathis, MD1Jean-Pierre Caujolle, MD2Juliette Thariat, MD, PhD3

JAMA Ophthalmol. 2020;138(1):e190388. doi:10.1001/jamaophthalmol.2019.0388


Clinical Science

The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma

Jinyu Yu ; Jiayi Yu ; Xiaowen Wu ; Qian Guo ; Ting Yin ; Zhiyuan Cheng ; Jie Dai ; Yan Kong ; Jun Guo

Clin Sci (Lond) (2020) CS20190890.

https://doi.org/10.1042/CS20190890


JAMA

Original Investigation

November 13, 2019

Age-Specific Incidence of Melanoma in the United States

Kelly G. Paulson, MD, PhD1,2,3Deepti Gupta, MD4,5,6Teresa S. Kim, MD3,7; et alJoshua R. Veatch, MD, PhD1,2,3David R. Byrd, MD3,7Shailender Bhatia, MD1,2,3Katherine Wojcik, PhD1Aude G. Chapuis, MD1,2,3John A. Thompson, MD1,2,3Margaret M. Madeleine, PhD, MPH8,9Jennifer M. Gardner, MD3,5

JAMA Dermatol. 2020;156(1):57-64. doi:10.1001/jamadermatol.2019.3353


CANCER CELL

 

ARTICLE| VOLUME 37, ISSUE 1, P55-70.E15, JANUARY 13, 2020

Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis

Douglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, Iman Osman, Iannis Aifantis, Eva Hernando,  et al  

DOI:https://doi.org/10.1016/j.ccell.2019.12.007


Cancer Cell

Volume 37, Issue 1, 13 January 2020, Pages 85-103.e9

 

Article

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance

Author links open overlay panelJose L.Orgaz12EvaCrosas-Molist1210AmineSadok310AnnaPerdrix-Rosell12410OscarMaiques1210IreneRodriguez-Hernandez1210JoMonger1SilviaMele5MirellaGeorgouli2VictoriaBridgeman4PanagiotisKaragiannis56RebeccaLee7PahiniPandya2LenaBoehme2FredrikWallberg8ChrisTape9Sophia N.Karagiannis5IlariaMalanchi4VictoriaSanz-Moreno1211

Show more

https://doi.org/10.1016/j.ccell.2019.12.003


Nature

 

Helmink, B.A., Reddy, S.M., Gao, J. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature (2020) doi:10.1038/s41586-019-1922-8


The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor

Elizabeth A. Coe, Jennifer Y. Tan, Michael Shapiro, Pakavarin Louphrasitthiphol, Andrew R. Bassett, Ana C. Marques, Colin R. Goding, Keith W. Vance 


REVIEW 

 Open Access

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review

Antonino GuerrisiEmiliano LoiSara UnganiaMichelangelo RussilloVicente BruzzanitiFulvia EliaFlora DesiderioRaffaella Marconi Francesco, Maria SolivettiLidia Strigari

First published: 17 January 2020 https://doi.org/10.1002/cam4.2709


Dove press

 

Does the Autophagy Related Gene 7 (ATG7) Have a Role in Non-Melanoma Skin Cancer?

Authors Samaka RM, Basha MA, Mansour E

Received 5 July 2019

Accepted for publication 29 November 2019

Published 20 January 2020 Volume 2020:13 Pages 49—58

DOI https://doi.org/10.2147/CCID.S222051


 

Menu